Ambeed.cn

首页 / / / / Echinatin/刺甘草查尔酮

Echinatin/刺甘草查尔酮 {[allProObj[0].p_purity_real_show]}

货号:A783726

Echinatin是从中草药甘草中分离得到,查尔酮,具有保肝和抗炎作用。在大鼠中,Echinatin 可以被快速吸收和消除并广泛分布,绝对生物利用度约为 6.81%。

Echinatin/刺甘草查尔酮 化学结构 CAS号:34221-41-5
Echinatin/刺甘草查尔酮 化学结构
CAS号:34221-41-5
Echinatin/刺甘草查尔酮 3D分子结构
CAS号:34221-41-5
Echinatin/刺甘草查尔酮 化学结构 CAS号:34221-41-5
Echinatin/刺甘草查尔酮 3D分子结构 CAS号:34221-41-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Echinatin/刺甘草查尔酮 纯度/质量文件 产品仅供科研

货号:A783726 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Autophagy 其他靶点 纯度
SBI-0206965 +++

ULK2, IC50: 711 nM

ULK1, IC50: 108 nM

95%
Hydroxychloroquine sulfate 99%
Valproic acid sodium HDAC 97%
PFK-015 ++

PFKFB3, IC50: 207 nM

99%+
MRT68921 HCl ++++

ULK2, IC50: 1.1 nM

ULK1, IC50: 2.9 nM

99%+
ROC-325 99%+
Autophinib +++

Autophagy, IC50: 40 nM

99%
Lys05 99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Echinatin/刺甘草查尔酮 生物活性

描述 Echinatin is a chalcone isolated from the Chinese herbal medicine Gancao with hepatoprotective and anti-inflammatory effects[3]. Administration of echinatin obviously inhibits NLRP3 inflammasome activation and ameliorates LPS-induced septic shock and dextran sodium sulfate-induced (DSS-induced) colitis in mice. Moreover, echinatin exerted favorable pharmacological effects on liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis (NASH)[4]. Echinatin induced apoptosis and autophagy through inactivation of AKT/mTOR signaling pathway, whereas constitutive activation of AKT significantly abrogated these effects. Furthermore, echinatin had a significant antitumor effect in the tumor xenograft model and markedly suppressed cell migration and invasion abilities of ESCC (Esophageal squamous cell carcinoma) cells in a dose-dependent manner[5]. Echinatin exerted its protective effect against MI/R (myocardial ischemic/reperfusion) injury at least partially by suppressing the Hippo/YAP signaling pathway[6]. Echinatin mitigates H2O2-induced oxidative damage and apoptosis in HLECs (Human lens epithelial B3 cells) via the Nrf2/HO-1 pathway, suggesting that Ech may be a potential drug for the treatment of cataracts[7].

Echinatin/刺甘草查尔酮 细胞实验

Cell Line
Concentration Treated Time Description References
THP-1 macrophages 10 μM 48 hours To evaluate the anti-inflammatory activity of Q-14 compounds. Echinatin demonstrated the most robust anti-inflammation activities (inhibition rate > 90%). Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120
human liver microsomes 25.86 μM 3 min or 33 min preincubation To evaluate the inhibitory effect of Echinatin on CYP3A, results showed that Echinatin inhibited CYP3A-catalyzed testosterone 6β-hydroxylation in a time-dependent manner, with IC50 values decreasing from 25.86 μM to 8.08 μM. Acta Pharmacol Sin. 2022 Apr;43(4):1072-1081
Calu-3 cells 1.1, 3.3, 10, 30 μM 48 hours To evaluate the inhibition effect of Echinatin on SARS-CoV-2-triggered inflammation. Echinatin reduced SARS-CoV-2-induced IL-1β P17 release in a dose-dependent manner. Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2301775120
KYSE270 cells 10 μM, 20 μM, 40 μM 24 h and 48 h To evaluate the effect of echinatin on ESCC cell apoptosis, the results showed that echinatin-induced apoptosis in a dose-dependent way. Cell Death Dis. 2020 Jul 13;11(7):524
KYSE30 cells 10 μM, 20 μM, 40 μM 24 h and 48 h To evaluate the effect of echinatin on ESCC cell apoptosis, the results showed that echinatin-induced apoptosis in a dose-dependent way. Cell Death Dis. 2020 Jul 13;11(7):524
KYSE270 cells 10 μM, 20 μM, 40 μM 5 days To evaluate the effect of echinatin on ESCC cell proliferation, the results showed that echinatin inhibited cell proliferation substantially in both dose- and time-dependent manner. Cell Death Dis. 2020 Jul 13;11(7):524
KYSE30 cells 10 μM, 20 μM, 40 μM 5 days To evaluate the effect of echinatin on ESCC cell proliferation, the results showed that echinatin inhibited cell proliferation substantially in both dose- and time-dependent manner. Cell Death Dis. 2020 Jul 13;11(7):524
mouse bone marrow-derived macrophages (BMDMs) below 100 μM 60 minutes To evaluate the effect of Echinatin on NLRP3 inflammasome activation, results showed that Echinatin significantly inhibited nigericin-induced caspase-1 activation, IL-1β maturation, and LDH release. JCI Insight. 2021 Jan 25;6(2):e134601
LO2 cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on LO2 cells Genes Dis. 2023 May 18;11(2):1050-1065
HS5 cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on HS5 cells Genes Dis. 2023 May 18;11(2):1050-1065
HEB cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on HEB cells Genes Dis. 2023 May 18;11(2):1050-1065
SV-HUC-1 cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the toxicity of Echinatin on normal human cells, the results showed that Echinatin had no significant toxicity on SV-HUC-1 cells Genes Dis. 2023 May 18;11(2):1050-1065
EJ cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the inhibitory effect of Echinatin on the proliferation of bladder cancer cells, the results showed that Echinatin significantly inhibited the proliferation of T24 and EJ cells Genes Dis. 2023 May 18;11(2):1050-1065
T24 cells 0, 20, 30, 40, 50 μM 24, 48, 72 hours To evaluate the inhibitory effect of Echinatin on the proliferation of bladder cancer cells, the results showed that Echinatin significantly inhibited the proliferation of T24 and EJ cells Genes Dis. 2023 May 18;11(2):1050-1065
MCF-7 >100 μM 48 hours Evaluated for cytotoxicity, results showed no significant activity Int J Mol Sci. 2021 Sep 18;22(18):10109
HT-29 >100 μM 48 hours Evaluated for cytotoxicity, results showed no significant activity Int J Mol Sci. 2021 Sep 18;22(18):10109
A375P >100 μM 48 hours Evaluated for cytotoxicity, results showed no significant activity Int J Mol Sci. 2021 Sep 18;22(18):10109

Echinatin/刺甘草查尔酮 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice KYSE270-derived tumor xenograft model Oral administration 20 mg/kg and 50 mg/kg Every 2 days To evaluate the inhibitory effect of echinatin on ESCC tumor growth, the results showed that echinatin significantly suppressed tumor growth without obvious toxicity to animals. Cell Death Dis. 2020 Jul 13;11(7):524
C57BL/6 mice LPS-induced septic shock model Intraperitoneal injection 20 mg/kg and 40 mg/kg Single dose To evaluate the protective effect of Echinatin on LPS-induced septic shock, results showed that Echinatin significantly reduced the levels of IL-1β and TNF-α in serum and improved the survival rate of mice. JCI Insight. 2021 Jan 25;6(2):e134601
BALB/c nude mice Bladder cancer xenograft model Oral gavage 0, 20, 40, 60 mg/kg Once every two days for 21 days To evaluate the inhibitory effect of Echinatin on tumor growth in a bladder cancer xenograft model, the results showed that Echinatin significantly inhibited tumor growth Genes Dis. 2023 May 18;11(2):1050-1065

Echinatin/刺甘草查尔酮 参考文献

[1]Fu Y, Chen J, et al. Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice. Food Chem. 2013 Nov 15;141(2):1063-71.

[2]Inoue B, Inaba K, et al. The effects of echinatin and its related compounds on the mitochondrial energy transfer reaction. J Toxicol Sci. 1982 Nov;7(4):245-54.

[3]Liang M, Li X, Ouyang X, Xie H, Chen D. Antioxidant Mechanisms of Echinatin and Licochalcone A. Molecules. 2018 Dec 20;24(1):3

[4]Xu G, Fu S, Zhan X, Wang Z, Zhang P, Shi W, Qin N, Chen Y, Wang C, Niu M, Guo Y, Wang J, Bai Z, Xiao X. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight. 2021 Jan 25;6(2):e134601

[5]Hong P, Liu QW, Xie Y, Zhang QH, Liao L, He QY, Li B, Xu WW. Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis. Cell Death Dis. 2020 Jul 13;11(7):524

[6]Niu J, Li Y, Song X, Liu Y, Li Y, Li Y. Cardioprotective Effect of Echinatin Against Ischemia/Reperfusion Injury: Involvement of Hippo/Yes-Associated Protein Signaling. Front Pharmacol. 2021 Jan 11;11:593225

[7]Ran H, Liu H, Wu P. Echinatin mitigates H2O2-induced oxidative damage and apoptosis in lens epithelial cells via the Nrf2/HO-1 pathway. Adv Clin Exp Med. 2021 Nov;30(11):1195-1203

Echinatin/刺甘草查尔酮 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.70mL

0.74mL

0.37mL

18.50mL

3.70mL

1.85mL

37.00mL

7.40mL

3.70mL

Echinatin/刺甘草查尔酮 技术信息

CAS号34221-41-5
分子式C16H14O4
分子量 270.28
SMILES Code O=C(C1=CC=C(O)C=C1)/C=C/C2=CC=C(O)C=C2OC
MDL No. MFCD00075719
别名
运输蓝冰
InChI Key QJKMIJNRNRLQSS-WEVVVXLNSA-N
Pubchem ID 6442675
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 120 mg/mL(443.98 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。